Kathryn Kruziki

Kathryn Kruziki is a highly experienced principal engineer currently leading R&D at AgThera Inc., focused on developing antimicrobial live biotherapeutics for intestinal infections. Kathryn also serves as a principal engineer at General Probiotics, Inc., where responsibilities include genetic engineering of antimicrobial probiotics, assay development, field testing, and optimization of processing methods. Previous experience includes roles as a graduate student research assistant at the University of Minnesota-Twin Cities, an undergraduate research assistant at the University of Massachusetts Amherst, a summer research assistant at the University of Colorado Boulder, and a protein purification intern at Shire Pharmaceuticals. Kathryn Kruziki holds a Ph.D. in Chemical Engineering from the University of Minnesota and a B.S. in Chemical Engineering from the University of Massachusetts Amherst.